<DOC>
	<DOCNO>NCT00298857</DOCNO>
	<brief_summary>The purpose study compare blood level valproic acid subject different body weight evaluate whether pharmacokinetic parameter drug alter obese population .</brief_summary>
	<brief_title>A Pharmacokinetic Study Compare Dosing Valproic Acid Subjects With Different Body Weights</brief_title>
	<detailed_description>Many pharmacologic agent dose base weight patient , study conduct determine appropriate dos drug patient different weight order find safe effective dose various weight . Valproic acid commonly use agent treatment epilepsy , well migraine headache psychiatric disorder . This prospective study design evaluate effect obesity pharmacokinetic parameter valproic acid compare individual healthy weight .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Male Female age 2160 year Normal healthy volunteer per interview screen Willing able provide write informed consent comply study protocol Inability take oral medication pregnant lactate female know hypersensitivity valproic acid BMI le 18.5 kg/m^2 BMI 25 29.9 kg/m^2 , inclusive Taking drug dietary supplement within one week prior study period Consumption food 6 hour prior study drug ingestion Know family history history urea cycle disorder Past history pancreatitis Past history liver disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Obesity</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>